House Agriculture Chairman Plants Seeds For FDA's CBD Policy With First Bill
Executive Summary
Minnesota Democrat Collin Peterson’s bill, the first targeting FDA’s CBD question, could provide an entire answer or it could set table for discussion in Congress about legislation on establishing an FDA regulation on using CBD, and potentially other hemp-derived substances, in products other than drugs subject to its oversight.
You may also be interested in...
CBD Safety And Hemp Farming Have Equal Space In Rep. Harris’ Concerns
“We ought to deal with this. There are questions on long-term safety and questions on efficacy claims that are just not proven,” says the Maryland Republican. “The biggest threat hanging over, in my mind, the farmers who want to grow hemp, is what if the FDA comes out tomorrow and says, ‘You can't sell any product’? The market collapses,”he said at a CBD policy conference.
FDA Gets Message In Congress' First Cannabis Policy Hearing: Deliver CBD Regulation
During first-ever congressional hearing on federal policies for lawful use of cannabis, House Energy and Commerce Health Subcommittee Chairwoman Anna Eschoo says with $2m appropriated to develop a regulation on CBD’s use in non-drug products during, FDA should deliver.
$2m For CBD Policy In FDA Budget, But No Directive On Setting Safe Level
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests:
